Katy Beckermann, MD, PhD, expresses her excitement about the upcoming 2023 International Kidney Cancer Symposium in Nashville. She highlights the conference's value in networking, sharing novel clinical data, and addressing the entire spectrum of kidney cancer. She notes that an update on the STELLAR-001 trial will be included, as well as discussions on challenging aspects of kidney cancer, such as rare tumor types.
The upcoming conference offers opportunities for interdisciplinary discussions among medical oncologists, scientists, surgeons, and radiation oncologists, fostering collaboration and advancing the field.
Medscape © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: IKCS 2023: Anticipating Data That Span the Breadth of Kidney Cancer - Medscape - Nov 02, 2023.
Comments